Antibodies under a microscope

Database

Filter by:

Antibody Category
Suppliers
Applications
Antibody Types
Host Species
Species Reactivity

You are searching for:

  • Category A

    • Original source/host: Naïve (human-derived B cell) or synthetic, natural or consensus framework (any species, published framework sequences) antibody or mimetic
    • Discovery method: Non-immunisation based in vitro display selection of antibody or mimetic
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    Search

  • Category B

    • Original source/host: Animal (historic hybridoma) OR naïve, non-immunised animal B cell-derived in vitro antibody display library
    • Discovery method: immunisation pre-2020 OR in vitro display selection of antibodies
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    • Recombinantly reformatted hybridomas are included as they align with the May 2020 EURL ECVAM recommendation, which permits continued use of existing, sequenced, and well-characterised hybridomas to produce recombinant monoclonal antibodies in vitro, as animals are no longer directly involved
    • Naïve, non-immunised animal B cell-derived in vitro antibody display libraries align with the May 2020 EURL ECVAM recommendation to no longer authorise the development and production of antibodies through animal immunisation
    Search

  • Category C

    • Original source/host: Naïve (human-derived B cell) or synthetic, natural or consensus framework (any species, published framework sequences) antibody or mimetic
    • Discovery method: Non-immunisation based in vitro display selection of antibody or mimetic
    • Production: Recombinant expression ; animal-derived biomaterials used in production or final formulation
    Search

  • Category D

    • Original source/host: Animal OR naïve, non-immunised animal B cell-derived in vitro antibody display library
    • Discovery method: immunisation pre-2020 OR in vitro display selection of antibodies
    • Production: Recombinant expression ; animal-derived biomaterials used in production or final formulation
    Search

  • Category E

    • Original source/host: Animal
    • Discovery method: immunisation-based selection post 2020
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    Search

  • Category F

    • Original source/host: Animal
    • Discovery method: immunisation-based selection post 2020
    • Production: Recombinant expression with animal-derived biomaterials used in production or final formulation
    Search

  • Category G

    • Original source/host: Unknown
    • Discovery method: Unknown
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    Search

2581-2590 of 4090 results

Catalogue Number:

PX-TA1451

Category:

G

Proteo Genix logo

Crizanlizumab Biosimilar – Anti-SELP mAb – Research Grade

Target: SELP
Target Alias Name: Crizanlizumab/SelG1/SELP/anti-SELP
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG2-kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo

Catalogue Number:

PX-TA1415

Category:

G

Proteo Genix logo

Crotedumab Biosimilar – Anti-GCGR mAb – Research Grade

Target: GCGR
Target Alias Name: Crotedumab/REGN-1193/GCGR/anti-GCGR
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG4-kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo

Catalogue Number:

PX-TA1497

Category:

G

Proteo Genix logo

Crovalimab Biosimilar – Anti-C5 mAb – Research Grade

Target: C5
Target Alias Name: Crovalimab/RG-6107/RO7112689/SKY-59/C5/anti-C5
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG1-kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo

Catalogue Number:

PX-TA1103

Category:

G

Proteo Genix logo

cT84.66 Biosimilar – Anti-CEACAM5/ CD66e mAb – Research Grade

Target: CEACAM5/ CD66e
Target Alias Name: cT84.66/90Y-cT84.66/CEACAM5/ CD66e/anti-CEACAM5/ CD66e
Species Reactivity: Human
Type: Primary Recombinant
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo

Catalogue Number:

PTX18543-100

Category:

G

Proteo Genix logo

CTGF / CCN2 Monoclonal Monoclonal Antibody 3B11

Target: CTGF
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG2a
Host Species: Mouse
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo

Catalogue Number:

PX-TA1651

Category:

G

Proteo Genix logo

Cudarolimab Biosimilar – Anti-TNFRSF4 mAb – Research Grade

Target: TNFRSF4
Target Alias Name: Cudarolimab/IBI-101/IMMUNOGLOBULIN G1/ ANTI-(HUMAN CD134 ANTIGEN) (HUMAN MONOCLONAL IBI101 .GAMMA.1-CHAIN)/ DISULFIDE WITH HUMAN MONOCLONAL IBI101 .KAPPA.-CHAIN/ DIMER/IMMUNOGLOBULIN G1-KAPPA/ ANTI-(HOMO SAPIENS TNFRSF4 (TUMOR NECROSIS FACTOR RECEPTOR (TNFR) SUPERFAMILY MEMBER 4/ ACT35/ OX40/ CD134))/ HOMO SAPIENS MONOCLONAL ANTIBODY/TNFRSF4/anti-TNFRSF4
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG1/Kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo

Catalogue Number:

PX-TA1500

Category:

G

Proteo Genix logo

Cusatuzumab Biosimilar – Anti-CD70/ TNFSF7 mAb – Research Grade

Target: CD70/ TNFSF7
Target Alias Name: Cusatuzumab/ARGX-110/CD70/ TNFSF7/anti-CD70/ TNFSF7
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG1-lambda
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo

Catalogue Number:

PX-TA1166

Category:

G

Proteo Genix logo

Dacetuzumab Biosimilar – Anti-CD40 mAb – Research Grade

Target: CD40
Target Alias Name: Dacetuzumab/SGN-40/huS2C/CD40/anti-CD40
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG1-kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo

Catalogue Number:

PX-TA1038

Category:

G

Proteo Genix logo

Daclizumab Biosimilar – Anti-IL2RA mAb – Research Grade

Target: IL2RA
Target Alias Name: Daclizumab/BIIB019/DAC HYP/IL2RA/anti-IL2RA
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG1-kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo

Catalogue Number:

PX-TA1652

Category:

G

Proteo Genix logo

Dafsolimab Biosimilar – Anti-CD3E mAb – Research Grade

Target: CD3E
Target Alias Name: Dafsolimab/DAFSOLIMAB [INN]/IMMUNOGLOBULIN G2B/ ANTI-(HUMAN CD3 ANTIGEN .EPSILON..DELTA. COMPLEX) (MUS MUSCULUS MONOCLONAL SPV-T3A .GAMMA.2B-CHAIN)/ DISULFIDE WITH MUS MUSCULUS MONOCLONAL SPV-T3A .KAPPA.-CHAIN/ DIMER/ IMMUNOGLOBULIN G2B-KAPPA/ ANTI-(CD3E (CD3 EPSILON/ LEU-4))/ MUS MUSCULUS MONOCLONAL ANTIBODY (DAFSOLIMAB)/CD3E/anti-CD3E
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG2b/Kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo